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Abstract: Neutrophils are key players in the early defense against invading pathogens. Due to their
potent effector functions, programmed cell death of activated neutrophils has to be tightly controlled;
however, its underlying mechanisms remain unclear. Fas ligand (FASL/CD95L) has been shown
to induce neutrophil apoptosis, which is accelerated by the processing of the BH3-only protein
BH3 interacting domain death agonist (BID) to trigger mitochondrial apoptotic events, and been
attributed a regulatory role during viral and bacterial infections. Here, we show that, in accordance
with previous works, mouse neutrophils underwent caspase-dependent apoptosis in response to
FASL, and that this cell death was significantly delayed upon loss of BID. However, pan-caspase
inhibition failed to protect mouse neutrophils from FASL-induced apoptosis and caused a switch
to RIPK3-dependent necroptotic cell death. Intriguingly, such a switch was less evident in the
absence of BID, particularly under inflammatory conditions. Delayed neutrophil apoptosis has been
implicated in several auto-inflammatory diseases, including inflammatory bowel disease. We show
that neutrophil and macrophage driven acute dextran sulfate sodium (DSS) induced colitis was slightly
more aggravated in BID-deficient mice, based on significantly increased weight loss compared to
wild-type controls. Taken together, our data support a central role for FASL > FAS and BID in mouse
neutrophil cell death and further underline the anti-inflammatory role of BID.
Keywords: neutrophil; FAS/CD95; BID; apoptosis; RIPK3; necroptosis; caspases; inflammation;
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1. Introduction
Neutrophils constitute the most abundant leukocytes in human peripheral blood and represent
the first line defense against invading pathogens such as bacteria, fungi and certain viruses [1,2].
In the absence of infections, neutrophils are rapidly turned over by spontaneous apoptosis with an
estimated lifespan of no more than a few days [3,4]. Importantly, bacterial components such as LPS
and pro-inflammatory cytokines such as granulocyte-macrophage colony-stimulating factor (GM-CSF)
prolong survival of neutrophils, which is crucial for an efficient antimicrobial response, by induction
of anti-apoptotic genes, including MCL-1, BFL-1/BCL-2-A1 or X-linked inhibitor of apoptosis
(XIAP) [5–8]. At a delayed stage, the same stimuli also induce pro-apoptotic BIM, thereby guaranteeing
the timely removal of activated neutrophils [7,9]. Extended survival of activated neutrophils is
Int. J. Mol. Sci. 2018, 19, 684; doi:10.3390/ijms19030684 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2018, 19, 684 2 of 15
known to cause collateral tissue damage and chronic inflammation. Dysregulated neutrophil death is
implicated in several diseases such as inflammatory bowel disease (IBD), rheumatoid arthritis, cystic
fibrosis and chronic obstructive pulmonary disease [3,10]. Therefore, neutrophil cell death must be
tightly controlled, which is achieved by engagement of death receptors, phagocytosis of pathogens or
decrease of survival factors [11]. However, the exact mechanisms of neutrophil cell death are not fully
understood. Recently, it was demonstrated that neutrophils are killed by engagement of the death
receptor FAS/CD95 during viral and bacterial infections [12,13]. FAS is constitutively expressed on
most cell types while its ligand, Fas ligand (FASL), is mainly expressed on activated T cells, NK and
NKT cells [14,15]. The FASL > FAS system is crucial in maintaining cellular homeostasis of the immune
system and in preventing development of autoimmunity and cancer [16]. Intriguingly, FASL > FAS
can not only induce apoptosis but also necroptosis, and is a potent inducer of NF-κB and chemokine
and cytokine production depending on the cellular context as well as on the form (i.e., soluble vs.
membrane-bound) of Fas ligand [17–19]. Soluble FASL induces cytokine production and survival
whereas only the membrane-bound form can elicit cell death [20]. Binding of the membrane-bound
FASL to its receptor triggers clustering of the receptors and formation of the death-inducing signaling
complex, DISC, which constitutes of FADD and procaspase-8 [21]. Formation of the DISC facilitates
the proteolytic trans auto-activation of pro-caspase-8 into its fully active form, which is then released
from the DISC into the cytosol. As a result, caspase-8 directly activates effector procaspase-3 and -7.
Caspase-8 also processes the BH3-only protein BH3 interacting domain death agonist (BID) into its
active form tBID (p15) and thereby amplifies the caspase activation cascade by engaging the intrinsic,
also called mitochondrial, apoptotic pathway [22,23].
According to their response to FAS stimulation, cells are divided in type I and type II like cells.
In type I cells, induction of the extrinsic pathway is sufficient to kill the cells whereas in type II cells,
for example in hepatocytes or pancreatic β cells, tBID-mediated crosstalk to the intrinsic pathway is
required for efficient FAS-induced cell death [24,25]. There is some evidence that loss of BID delays
FASL-induced neutrophil death, suggesting that neutrophils are type II-like cells, whereas, interestingly,
TNFα > TNF-R1-induced neutrophil cell death does not depend on BID [26,27].
Neutrophils are crucial players in the maintenance of intestinal homeostasis but their accumulation
in the intestine results in mucosal injury and thereby promotes development of IBD [28]. Dextran
sulfate sodium (DSS)-induced colitis depends on neutrophils and macrophages and is a suitable model
to mimic clinical manifestations of IBD observed in humans. DSS affects epithelial cells in the colon
and causes disruption of the epithelial barrier. As a consequence DSS and other large molecules
may penetrate the colon mucosa and trigger an inflammatory response involving neutrophils [29].
Programmed cell death of activated neutrophils (and subsequent elimination by macrophages), which
is delayed in patients suffering from IBD, is absolutely critical for the resolution of inflammation [28].
This is also supported from studies in mice in which depletion of neutrophils diminished the severity
of DSS-induced colitis [30]. Furthermore, enhanced expression of FASL could be detected in inflamed
intestine and therefore, FASL may promote resolution of experimental colitis [31]. In line with this
observation, mice expressing a signaling deficient mutant of FAS (lprcg mice) are more susceptible to
DSS-induced colitis [32].
Here, we examined the regulation of FASL > FAS induced cell death in mouse neutrophils and the
involvement of BID in these processes. We observed that loss of BID did not abolish but significantly
delayed FASL-mediated effector caspase activation and subsequent cell death, strongly supporting the
notion that neutrophils are type II-like cells. Even though neutrophils underwent caspase-mediated
apoptosis in response to FASL, pan-inhibition of apoptotic caspases could not fully restore viability.
Additional enzymatic inhibition of RIPK1 or genetic ablation of RIPK3 was required to protect neutrophils
from FASL-induced killing suggesting that a switch to necroptosis occurs when caspases are blocked.
To support our in vitro findings, we compared WT and Bid−/− mice in an acute DSS-colitis model.
We observed that loss of BID worsened the severity of colitis, based on the overall weight loss, and
delayed resolution probably due to accumulation of activated neutrophils in the colon. Overall, our
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results implicate that BID importantly regulates neutrophil death in the context of FASL > FAS and
DSS colitis and that through this anti-inflammatory function BID may counteract development of
inflammatory diseases such as IBD.
2. Results
2.1. Fas Ligand (FASL) Induces Neutrophil Death, Which Is Delayed in Absence of BH3 Interacting Domain
Death Agonist (BID)
Upon in vitro culturing in the absence of specific cytokines, neutrophils undergo spontaneous
apoptosis. As shown in Figure 1a, spontaneous apoptosis of primary bone marrow-derived mouse
neutrophils occurred by a classical caspase-dependent mechanism, as it was fully blocked by the
pan-caspase inhibitor Q-VD-OPh. Wild-type (WT) and Bid−/− neutrophils died with the same kinetics,
indicating that BID does not contribute to spontaneous neutrophil apoptosis (Figure 1a,b). We next
tested the effect of crosslinked FASL on the viability of WT and Bid−/− neutrophils over time. Primary
neutrophils were isolated from the bone marrow of mice or, alternatively, neutrophils were differentiated
in vitro using conditional Hoxb8, which allows working with many cells [33–35]. Primary as well
as in vitro differentiated WT neutrophils were highly sensitive to FASL-induced cell death, whereas
cell death was significantly delayed upon loss of BID (Figures 1b and S1a). Of note, Bim−/− primary
neutrophils died with the same kinetics in response to FASL as WT controls (Figure S2). Interestingly,
pan-inhibition of apoptotic caspases by Q-VD-OPh had only a partial protective effect from FASL in WT
cells, whereas the viability of Bid−/− neutrophils was again higher and comparable to untreated controls
(Figures 1c and S1b). Additional inhibition of the enzymatic activity of RIPK1 by necrostatin-1 was
required to further increase viability in FASL-treated cells (Figures 1c and S1b). However, necrostatin-1
alone had no protective effect (Figure 1c). Furthermore, genetic ablation of RIPK3 resulted in a full
protection from FASL-induced killing by Q-VD-OPh, with significantly higher viabilities compared to
untreated controls (spontaneous apoptosis) at later timepoints (Figures 1d and S1c). Taken together,
these data suggest that FASL-induced apoptosis may switch to RIPK1- and RIPK3-dependent cell death
when caspases are blocked and that, interestingly, BID seems to contribute to such a switch.
2.2. Neutrophils Undergo Apoptosis in Response to FASL, Which Switches to Necroptosis Upon Inhibition
of Caspases
To further investigate the type of FASL-induced cell death, we analyzed protein lysates prepared
from FASL-stimulated neutrophils at various time points by immunoblotting. As shown in Figure 2a,c,
stimulation of FASL caused rapid processing of initiator caspase-8 into its fully active p18 fragment
in WT cells. Cleavage of caspase-8 concurred with processing of procaspase-3 into its active form as
well as cleavage of the caspase-3 substrate PARP. Additionally, enzymatic activation of caspase-3/-7
was confirmed by fluorogenic DEVDase assay. Caspase-3/-7 activity was observed within a few
hours and peaked after 4 h. However, in absence of BID, much lower caspase-3/-7 processing and
enzymatic activity levels could be measured, consistent with the observed delay in cell death in
Figure 1 (Figure 2a–c). Moreover, a slight decrease in XIAP protein expression was detected over time
in WT neutrophils, which was not apparent in the absence of BID (Figure 2a). Interestingly, cIAP1
protein levels strongly decreased in response to FASL in both WT and Bid−/− neutrophils through
a caspase-dependent mechanism (Figure 2c). Due to the findings that inhibition of caspases could
not fully restore viability upon FASL treatment, translocation of MLKL from an aqueous fraction to
a detergent (integral membrane enriched) fraction, which is considered a hallmark of necroptosis [36],
was assessed. MLKL was found only in the aqueous fraction in response to FASL alone while
upon blockage of caspases MLKL was also found in the detergent fraction in both WT and Bid−/−
neutrophils, suggesting translocation of MLKL to membranes (Figure 2d). Taken together, our data
show that, in response to FASL, mouse neutrophils undergo caspase-dependent apoptosis, which is
accelerated by BID. However, in the absence of caspase activity cell death switches from apoptosis to
necroptosis with translocation of MLKL to membranes.
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Figure 1. Mouse neutrophils undergo cell death in response to FASL, which is delayed by loss of BID. 
(a) Assessment of viability of WT and Bid−/− neutrophils left untreated (spontaneous apoptosis) or 
treated with the pan-caspase inhibitor Q-VD-OPh (20 μM) for indicated time points. n ≥ 6, mean ± 
SEM. (b) Assessment of viability of WT and Bid−/− neutrophils upon treatment with FASL (100 ng/mL) 
for indicated time points. n ≥ 3, mean ± SEM. (c) WT and Bid−/− neutrophils were pre-treated with Q-
VD-OPh (20 μM) and/or Nec.1 (20 μM) for 30 min followed by treatment with FASL (100 ng/mL) for 
indicated time points. Viability was assessed by flow cytometry. n ≥ 4, mean ± SEM. (d) Ripk3−/− 
neutrophils were pre-treated with Q-VD-OPh (20 μM) for 30 min and subsequently stimulated with 
FASL (100 ng/mL) for indicated time points. Viability was assessed by flow cytometry using GFP-
AnnexinV/PI exclusion. n = 3, mean ± SEM. All experiments were performed with primary bone 
marrow-derived neutrophils. p < 0.05 (*), p < 0.01 (**), p < 0.005 (***) and p < 0.001 (****). 
Figure 1. Mouse neutrophils undergo cell death in response to FASL, which is delayed by loss of BID.
(a) Assessment of viability of WT and Bid−/− neutrophils left untreated (spontaneous apoptosis) or
treated with the pan-caspase inhibitor Q-VD-OPh (20 µM) for indicated time points. n ≥ 6, mean ± SEM.
(b) Assessment of viability of WT and Bid−/− neutrophils upon treatment with FASL (100 ng/mL)
for indicated time points. n ≥ 3, mean ± SEM. (c) WT and Bid−/− neutrophils were pre-treated with
Q-VD-OPh (20 µM) and/or Nec.1 (20 µM) for 30 min followed by treatment with FASL (100 ng/mL)
for indicated time points. Viability was assessed by flow cytometry. n ≥ 4, mean ± SEM. (d) Ripk3−/−
neutrophils were pre-treated with Q-VD-OPh (20 µM) for 30 min and subsequently stimulated with FASL
(100 ng/mL) for indicated time points. Viability was assessed by flow cytometry using GFP-AnnexinV/PI
exclusion. n = 3, mean ± SEM. All experiments were performed with primary bone marrow-derived
neutrophils. p < 0.05 (*), p < 0.01 (**), p < 0.005 (***) and p < 0.001 (****).
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Figure 2. FASL induces apoptosis in neutrophils, which switches to necroptosis when caspases are 
inhibited. (a) WT and Bid−/− neutrophils were treated with FASL (100 ng/mL) for 0–8 h. Lysates were 
assessed by immunoblotting. Presented immunoblots are representative of at least two independent 
experiments. * indicates non-specific bands; ** indicates bands derived from previous anti-BID 
immunoblotting. (b) WT and Bid−/− neutrophils were stimulated with FASL (100 ng/mL) for indicated 
time points. Lysates were assayed for caspase-3/-7 activity by fluorogenic DEVDase assay. n ≥ 3, mean 
± SEM. p < 0.05 (*), p < 0.01 (**). (c) WT and Bid−/− neutrophils were pre-treated with Q-VD-OPh (20 
μM) for 30 min and subsequently treated with FASL (100 ng/mL) for 6 h. Lysates were subjected to 
immunoblotting. Presented immunoblots are representative of at least two independent experiments. 
(d) WT and Bid−/− neutrophils were pre-stimulated with Q-VD-OPh (20 μM) for 30 min followed by 
administration of FASL (100 ng/mL) for 16 h. Fractionation by phase separation was performed and 
lysates were subjected to immunoblotting. Presented immunoblots are representative of at least two 
independent experiments. All experiments were performed with in vitro differentiated neutrophils. 
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encountered in an inflammatory environment. The pro-inflammatory cytokine GM-CSF as well as 
bacterial endotoxin LPS are known to prime neutrophils and to prolong their survival [5,34]. We have 
recently shown that unprimed neutrophils are sensitive to TNFα-induced apoptosis, whereas this 
effect is fully lost upon priming with GM-CSF [34]. In contrast, GM-CSF-primed primary as well as 
in vitro differentiated WT neutrophils remained highly sensitive to FASL-induced cell death, and loss 
of BID slightly but significantly delayed death kinetics (Figures 3a and S3). GM-CSF-primed WT 
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Figure 2. FASL induces apoptosis in neutrophils, which switches to necroptosis when caspases r inhibited.
(a) WT and Bid−/− neutrophils were treated with FASL (100 ng/mL) for 0–8 h. Lysates were assessed by
immunoblotting. Presented immunoblots are representative of at least two independent experiments.
* indicates non-specific bands; ** indicates bands derived from previous anti-BID immunoblotting.
(b) WT and Bid−/− neutrophils were stimulated with FASL (100 ng/mL) for indicated time points. Lysates
were assayed for caspase-3/-7 activity by fluorogenic DEVDase assay. n ≥ 3, mean ± SEM. p < 0.05 (*),
p < 0.01 (**). (c) WT and Bid−/− neutrophils were pre-treated with Q-VD-OPh (20 µM) for 30 min and
subsequently treated with FASL (100 ng/mL) for 6 h. Lysates were subjected to immunoblotting. Presented
immunoblots are representative of at least two independent experiments. (d) WT and Bid−/− neutrophils
were pre-stimulated with Q-VD-OPh (20 µM) for 30 min followed by adminis ration of FASL (100 g/mL)
for 16 h. Fractionation by phase separation was performed and lysates were subjec ed t immunobl tting.
Presented immunoblots are representative of at least tw independe t experiments. All experiments were
performed with in vitro differentiated neutrophils.
2.3. FASL Efficiently kills Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)- and LPS-Primed
Neutrophils
We then examined the effect of FASL on primed neutrophils, thus mimicking the conditions
encountered in an inflammatory environment. The pro-inflammatory cytokine GM-CSF as well as
bacterial endotoxin LPS are known to prime neutrophils and to prolong their survival [5,34]. We have
recently shown that unprimed neutrophils are sensitive to TNFα-induced apoptosis, whereas this
effect is fully lost upon priming with GM-CSF [34]. In contra t, GM-CSF-primed pri ary as well
as in vitro differentiated WT neutrophils remained highly sensitive to FASL-induced cell death, and
loss of BID slightly but significantly delayed death kinetics (Figures 3a and S3). GM-CSF-primed WT
neutrophils could only be partly protected by pan-caspase inhibition whereas neither inhibition of
RIPK1 nor MLKL had a protective effect on their own (Figure 3b). Intriguingly, GM-CSF primed Bid−/−
neutrophils could be fully protected with the pan-caspase inhibitor Q-VD-OPh, indicating that, under
primed conditions, BID importantly contributes to the switch from apoptosis to caspase-independent
cell death (Figure 3b). This caspase-independent cell death is likely necroptosis, as GM-CSF primed
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Ripk3−/− neutrophils remained sensitive to FASL but this cell death was now fully blockable by
pan-caspase inhibition (Figure 3c). In contrast to unprimed neutrophils, primed neutrophils died with
slower kinetics. Cleaved caspase-8 and -3 could be detected at later time points compared to unprimed
neutrophils, which correlated with delayed cell death. Again, a decrease over time of XIAP in WT,
but not Bid−/−, neutrophils could be observed (Figure 3d).
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(100 ng/mL) for indicated time points. Viability was assessed by flow cytometry. n ≥ 3, mean ± SEM. 
(b) Primary WT and Bid−/− neutrophils were primed with GM-CSF (1 ng/mL) for 30 min and pre-
treated with either Q-VD-OPh (20 μM), Nec.1 (20 μM) or the mouse MLKL inhibitor GW806742X  
(1 μM) for 30 min followed by stimulation with FASL (100 ng/mL) for indicated time points. Viability 
was assessed by flow cytometry. n ≥ 3, mean ± SEM. (c) In vitro differentiated Ripk3−/− neutrophils 
were primed with GM-CSF (1 ng/mL) for 30 min prior to stimulation with FASL (100 ng/mL) with or 
without Q-VD-OPh (20 μM) for indicated time points. Viability was assessed by flow cytometry.  
n ≥ 3, mean ± SEM. (a–c): p < 0.05 (*), p < 0.01 (**), p < 0.005 (***) and p < 0.001 (****). (d) In vitro 
differentiated WT and Bid−/− neutrophils were primed with GM-CSF (1 ng/mL) for 30 min and 
subsequently treated with FASL (100 ng/mL) for 0–8 h. Lysates were assessed by immunoblotting. 
Presented immunoblots are representative of at least two independent experiments. 
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Figure 3. GM-CSF-primed neutrophils remain sensitive to FASL killing. (a) Primary WT and
Bid−/− neutrophils were primed with GM-CSF (1 ng/mL) for 30 min prior to stimulation with FASL
(100 ng/mL) for indicated time points. Viability was assessed by flow cytometry. n ≥ 3, mean ± SEM.
(b) Primary WT and Bid−/− neutrophils were primed with GM-CSF (1 ng/mL) for 30 min and
pre-treated with either Q-VD-OPh (20 µM), Nec.1 (20 µM) or the mouse MLKL inhibitor GW806742X
(1 µM) for 30 min followed by stimulation with FASL (100 g/mL) for indicated time points. V ability
was assessed by flow cytometry. ≥ 3, mean ± SEM. (c) In vitro differentiated Ripk3−/− neutrophils
were primed with GM-CSF (1 ng/mL) for 30 min prior to stimulation with FASL (100 ng/mL) with or
without Q-VD-OPh (20 µM) for indicated time points. Viability was assessed by flow cytometry. n ≥ 3,
mean± SEM. (a–c): p < 0.05 (*), p < 0.01 (**), p < 0.005 (***) and p < 0.001 (****). (d) In vitro differentiated
WT and Bid−/− neutrophils were primed with GM-CSF (1 ng/mL) for 30 min and subsequently treated
with FASL (100 ng/mL) for 0–8 h. Lysates were assessed by immunoblotting. Presented immunoblots
are representative of at least two independent experiments.
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Similar to GM-CSF priming, LPS primed WT, Bid−/− and Ripk3−/− neutrophils were as sensitive
as unprimed neutrophils to FASL-induced cell death, with Bid−/− cells being more resistant than
WT controls (Figures 4a–d and S4). Furthermore, caspase inhibition resulted in a complete rescue of
Ripk3−/− neutrophils and viabilities were significantly higher in Bid−/− neutrophils compared to WT
controls (Figure 4b,c). Taken together, GM-CSF- or LPS-primed neutrophils remain highly sensitive
to FASL-induced cell death and retain their type II characteristics. Furthermore, when caspases are
blocked upon FASL stimulation, caspase-independent and RIPK3-dependent cell death is enabled by
a mechanism facilitated by BID.
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Figure 4. LPS-primed neutrophils remain sensitive to FASL killing. (a) Primary WT and Bid−/−
neutrophils were primed with LPS (10 ng/mL) for 30 min prior to stimulation with FASL (100 ng/mL)
for indicated time points. Viability was assessed by flow cytometry. n ≥ 3, mean ± SEM. (b) Primary
WT and Bid−/− neutrophils were primed with LPS (10 ng/mL) for 30 min, pre-treated with either
Q-VD-OPh (20 µM), Nec.1 (20 µM) or the mouse MLKL inhibitor GW806742X (1 µM) for 30 min followed
by stimulation with FASL (100 ng/mL) for indicated time points. Viability was assessed by flow cytometry.
n = 3, mean± SEM. (c) In vitro differentiated Ripk3−/− neutrophils were primed with LPS (10 ng/mL) for
30 min prior to stimulation with FASL (100 ng/mL) with or without Q-VD-OPh (20 µM) for indicated time
points. Viability was assessed by flow cytometry. n ≥ 3, mean ± SEM. (a–c): p < 0.05 (*), p < 0.01 (**) and
p < 0.005 (***). (d) In vitro differentiated WT and Bid−/− neutrophils were primed with LPS (1 ng/mL)
prior to s imulation with FASL (100 g/mL) for 0–8 h. Lysates were subj cted to immunoblot. Presented
immunoblots are re resentative of at least two independent experiments.
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2.4. Dextran Sulfate Sodium (DSS)-Induced Weight Loss in Mice Is Aggravated in the Absence of BID
To investigate the role of BID in development and resolution of acute colitis mediated predominantly
by neutrophils and macrophages, we added 3% DSS to the drinking water for five days (Figure 5a).
There was no difference in colon lengths between untreated WT and Bid−/− mice (WT: 8.54 ± 0.24 cm,
Bid−/−: 8.44 ± 0.28 cm; means ± SEM, n = 5 per genotype). Both WT and Bid−/− mice developed colitis
over time observed by constant weight loss and shortening of their colons (Figure 5b,c). As soon as
DSS-containing water was replaced by normal water at Day 5 mice started to recover and gained weight
again from Day 7 onwards. However, the weight loss in Bid−/− mice was significantly more pronounced
compared to WT mice and recovery phase was delayed (Figure 5b). DSS treated Bid−/− mice showed
a trend to shortened colons—consistent with increased inflammation—at the endpoint of eight days
compared to WT mice, but this did not reach statistical significance (Figure 5c). Histopathological scoring
from colon samples of Bid−/− as well as WT mice displayed minor differences (Figure 5d). Slightly
higher Tnfα and Il-6 mRNA levels could be quantified in colon pieces from Bid−/− mice after five days
of treatment compared to WT controls (Figure 5e). Furthermore, differences in number of neutrophils
in inflamed colon pieces were investigated. The matrix metalloprotease MMP9 was used as indication
for neutrophil numbers, as activated neutrophils are a major source of this protease. Mmp9 mRNA was
slightly higher in colons of Bid−/− mice after five days of treatment, suggesting a higher neutrophil
count in the colon (Figure 5f).
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Figure 5. DSS-induced colitis is mildly exacerbated upon loss of BID. Colitis induced by 3% DSS in WT
and Bid−/− mice (n = 12–14 animals per time point and group). (a) Scheme of the experimental set up.
(b) Time course of weight loss (p < 0.05 (*), p < 0.01 (**), p < 0.005 (***) and p < 0.001 (****)) and (c) colon
length after Day 5 and Day 8 of treatment. (d) Histology of colon tissues stained with H&E after Day 5
and Day 8 of treatment and analysis of severity of colitis by histological scoring. Presented images are
representative. (e) Relative Tnfα and Il-6 mRNA expression in colon tissues after five days of treatment.
Gapdh was used as reference gene. (f) Relative Mmp9 mRNA expression in colon tissues after five days
of treatment. Gapdh was used as reference gene.
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3. Discussion
Neutrophils are crucial for the first line defense against invading pathogens. Their lifespan has
to be tightly controlled, especially once they enter an activated state, and neutrophil cell death is
achieved amongst others by engagement of the death receptor FAS, which is constitutively expressed
on neutrophils [1,2,11]. FAS has been proposed to contribute to the resolution of inflammation by
killing immune cells including neutrophils [12,13,16]. To date, it has been shown that neutrophils
undergo caspase-mediated apoptosis, which is fully blockable with pan-caspase inhibitors in human
neutrophils [10,37]. We confirmed that the spontaneous cell death observed upon culturing of mouse
neutrophils in the absence of specific cytokines occurs by classical caspase-dependent apoptosis.
We focused our study on FASL > FAS mediated signaling in mouse neutrophils and could demonstrate
that mouse neutrophils are highly sensitive to FASL and likewise undergo caspase-dependent
apoptosis. However, and in contrast to human neutrophils, we show that FASL-induced cell death in
mouse neutrophils switches to RIPK3-dependent necroptosis under conditions of caspase inhibition
(Figures 1 and 2). These findings are somewhat surprising, since we recently published that
TNFα > TNF-R1 induced apoptosis in mouse neutrophils is fully blockable using a pan-caspase
inhibitor [34]. As a possible reason might be the observed decrease in cIAP1 (and in WT cells also
XIAP) protein expression found upon FASL stimulation. It has been shown for TRAIL-induced
apoptosis that cIAP1 and XIAP are degraded by caspase-8 and the latter also by caspase-9 [38].
Whether this holds also true for FASL-induced neutrophil apoptosis is not clear and needs further
investigation. Furthermore, the question arises why human neutrophils can apparently be protected
from FAS-induced cell death by blocking caspases. One possible explanation could be the relatively
high expression levels of RIPK3, RIPK1 and MLKL proteins in mouse neutrophils, which make them
more prone to undergo necroptosis (Figures 2–4) [34]. In contrast, RIPK3 protein expression levels
seem to vary in humans from donor to donor and can be very low based on immunoblotting (personal
communication Dr. X Wang, University of Bern, Switzerland).
In agreement with previous works [26,27], we show that loss of BID delays neutrophil apoptosis
induced by FASL underlining that neutrophils are type II cells. This contribution of BID to FASL-induced
killing was further increased when neutrophils were primed with GM-CSF or bacterial LPS, supporting
the importance of BID in cell death regulation of neutrophils in an inflammatory environment. When
such an inflammatory environment was mimicked by addition of GM-CSF or LPS prior to stimulation
with FASL, the primed neutrophils remained highly sensitive to FASL-induced killing, in sharp contrast
to earlier findings on TNFα induced neutrophil death (34). This finding is in agreement with a previous
report [39] and supports the notion that FAS may have crucial roles in controlling neutrophil death in order
to resolve inflammation (Figures 3 and 4) [16]. Intriguingly, the switch from apoptosis to RIPK3-dependent
necroptosis observed under caspase inhibiting conditions seems to be at least partially dependent on BID,
as it was less obvious in unprimed Bid−/− neutrophils and basically absent in GM-CSF- or LPS-primed
Bid−/− neutrophils (Figures 1c, 3b and 4b). These data suggest a connection from BID, and thus likely
from BID-mediated mitochondrial apoptotic events, to induction of RIPK3-dependent necroptosis. Even
though such a connection is poorly understood and needs further investigation, a recent report by
Giampazolias and colleagues showed that mitochondrial outer membrane permeabilisation (MOMP) can
engage necroptosis [40].
Prolonged survival of activated neutrophils causes tissue damage and is implicated in numerous
diseases including IBD and rheumatoid arthritis [3]. We used the DSS-induced colitis model in mice to
investigate the role of BID in development and resolution of colitis (Figure 5). Based on the weight
loss during the experiment, Bid−/− mice developed worse colitis with delayed resolution compared to
WT mice. These findings are in line with our in vitro data showing loss of BID has a positive impact
on survival of FASL-treated neutrophils. Prolonged survival of activated neutrophils would thereby
result in aggravated and extended inflammation. Even though the observed effects were modest, and
with the exception of the weight loss did not reach statistical significance, our data are supportive
of an anti-inflammatory role of BID [41] and do not confirm a recently proposed pro-inflammatory
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role [42]. However, a limitation of our in vivo study is the use of a conventional Bid−/− mouse strain
that lacks BID expression in all cell types. Loss of BID could also have an impact in other cells, such as
macrophages or colon epithelial cells. Generation of conditional transgenic mice, such as for example
a neutrophil-specific Bid-deficient strain, would allow definitive conclusions about the specific role of
BID in neutrophils in DSS-induced colitis.
In summary, we show that BID is an important regulator downstream of FAS in mouse neutrophils.
Loss of BID significantly delays FASL-cell death and partially counteracts the switch from apoptosis to
necroptosis when caspases are blocked. Additionally, and in contrast to TNF-R1 signaling [34], GM-CSF-
as well as LPS-primed neutrophils remain sensitive to FASL-induced cell death which supports a role of
the FASL > FAS system in the regulation of neutrophil cell death under inflammatory conditions.
4. Materials and Methods
4.1. Mice and Reagents
C57BL/6 mice were maintained under pathogen-free conditions in IVC cages. Bid−/− [43] and
Ripk3−/− mice [44] have been previously described. All animals were approved by the animal
experimentation review board of the canton of Bern (BE4/12, BE31/1 and BE12/14).
RPMI-1640 AQmediaTM, propidium iodide (PI) and 4-hydroxytamoxifen (4-OHT) were from
Sigma-Aldrich Chemie (Buchs, Switzerland). Penicillin/streptomycin and 2-mercaptoethanol (2-ME)
were purchased from Life Technologies (Carlsbad, CA, USA). CHO/SCF (mm) conditioned medium
(used as a source of mouse stem cell factor) was produced as previously described [45]. Recombinant
His6-tagged GFP-Annexin V was purified as previously described [46]. Fetal calf serum (FCS, Sera Pro,
ultra-low endotoxin) was from Pan Biotech (Aidenbach, Germany). Recombinant FLAG-FASL (human)
and necrostatin-1 were purchased from Enzo LifeSciences AG (Lausen, Switzerland). Q-VD-OPh
was from SM Biochemicals (Anaheimm, CA, USA). GW806742X was from Synkinase (Parkville, VIC,
Australia). Ultrapure LPS (E. coli K12) was from Invivogen (San Diego, CA, USA). Recombinant mouse
GM-CSF was purchased from Peprotech (Rocky Hill, NJ, USA).
4.2. Isolation of Primary Neutrophils from Murine Bone Marrow
Cells were harvested from femoral bones. Primary neutrophils cells were isolated using rat
anti-Gr-1 antibody (clone RB6-8C5, BioLegend, San Diego, CA, USA) by magnetic bead based cell sorting
following the manufacturer’s instructions (BD IMagTM, BD Biosciences, San Jose, CA, USA). The purity
was in general above 95% as assessed by morphology following staining with DiffQuik solution
(Baxter, Deerfield, IL, USA). Neutrophils were cultivated in RPMI-1640 AQmedia complemented with
10% FCS, penicillin/streptomycin and 50 µM 2-ME.
4.3. Generation and In Vitro Differentiation of Mouse Neutrophils
Conditional Hoxb8 immortalized neutrophil/macrophage committed myeloid progenitors,
termed SCF-condHoxb8 cells, were generated from bone marrow of WT, Bid−/− and Ripk3−/− mice
as previously described [35,45,47]. Cells were cultivated in RPMI-1640 AQmedia complemented
with 10% FCS, penicillin/streptomycin, 0.1 µM 4-OHT and 5% CHO/mmSCF-conditioned medium.
Upon removal of 4-OHT, cells differentiated into mature neutrophils within 5 days. To confirm
successful differentiation the following surface markers profile was used: Gr-1(Ly-6C/Ly-6G)hi CD11b+
CD117(c-kit)neg, using the following antibodies from BioLegend (San Diego, CA, USA): rat anti-CD11b
(clone M1/70), rat anti-Gr-1 (clone RB6-8C5), and rat anti-CD117 (c-kit, clone 2B8). All experiments
were performed with mature neutrophils.
4.4. Gel Electrophoresis and Immunoblotting
Cells were lysed in hot H8-Buffer (20 mM Tris/HCL pH 7.5, 2 mM EGTA, 2 mM EDTA, 1% SDS,
supplemented before us with 50 mM DTT). Proteins were denatured in 4× Lämmli Buffer (complemented
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with 50 mM DTT), separated on 7.5–12.5% denaturing SDS-PAGE gels and subsequently transferred to
PDVF membrane (Immobilon-FL, 0.45 µM, Merck Millipore, Zug, Switzerland). Membranes were
probed with primary antibodies including: mouse anti-RIPK1 (clone 610458), mouse anti-PARP
(clone C2-10), mouse anti-actin (C4/actin) and mouse anti-XIAP (clone 28/hILP/XIAP) from BD
BioSciences; rabbit polyclonal anti-RIPK3 (Pro-Sci, #2283); rat anti-MLKL (clone 3H1; kind gift from
W. S. Alexander, Melbourne); rabbit polyclonal anti-procaspase-3 (#9662), anti-cleaved caspase-3 (#9661)
and rabbit anti-cleaved-caspase-8 (clone D5B2) from Cell Signaling; rat anti-procaspase-8 (clone 1G12,
kind gift from L. O’Reilly, Melbourne); mouse anti-GAPDH (clone 6C5, Merck Millipore); rat anti-BID
(clones 2D1 and 8C3; kind gift from D. Huang, Melbourne); mouse anti-porin (clone 89-173/016)
from Calbiochem. Infrared dye-conjugated secondary antibodies (LI-COR Biosciences, Bad Homburg,
Germany) were used for quantitative immunoblotting. Alternatively, horseradish peroxidase-conjugated
secondary antibodies (Jackson ImmunoResearch Europe Ltd., Newmarket SFK, UK) were used and
signals were obtained by enhanced chemiluminescence (LuminataTM Forte Western HRP substrate,
Merck Millipore). Immunoblots were analyzed with the Odyssey® Fc Dual-Mode Imaging System using
the ImageStudio software 3.1.4 (LI-COR).
4.5. Assessment of Cell Death by Flow Cytometry
Neutrophils were stained with GFP-Annexin V diluted in FACS Buffer (150 mM NaCl, 4 mM KCl,
2.5 mM CaCl2, 1 mM MgSO4, 15 mM HEPES pH 7.2, 2% FCS and 10mM NaN3) for 20 min on ice in
the dark. After a washing step, propidium iodide (2 µg/mL) was added to the cells. Viability was
determined by flow cytometry and analyzed using WEASEL version 3.0.2 [48]. Cells negative for both
GFP-Annexin V and propidium iodide were considered as viable.
4.6. Detection of Active Caspase-3 and -7 Activity
A fluorometric assay with DEVD-AMC as substrate was performed to measure enzymatic activity
of caspase-3 and -7 (Bachem, Bubendorf, CH). First, 1 × 106 neutrophils were lysed in 50 µL digitonin
lysis buffer (20 mM HEPES pH 7.4, 100 mM sucrose, 25 mM MgCl2, 100 mM KCl, protease inhibitor
cocktail (Roche Complete protease inhibitor cocktail plus 1 µg/mL pepstatin), 1 mM DTT, 0.025%
digitonin). Protein concentrations were assessed by BCA protein assay according to the manufacturer’s
instructions (Thermo Fisher Scientific, Waltham, MA, USA). Protein lysates (10–25 µg) were mixed
with assay buffer (0.1 M HEPES pH 7.5, 10% sucrose, 0.1% CHAPS, 10 mM DTT) complemented with
500 µM DEVD-AMC (final concentration 50 µM). Enzymatic activity was quantified kinetically for one
hour (1-min intervals) on a SpectraMax M2e plate reader (Molecular Devices, San Jose, CA, US).
4.7. Fractionation by Phase Separation
Fractionation was adapted from [49] and performed as previously described [34].
4.8. DSS-Induced Colitis
Eight- to twelve-week-old WT and Bid−/− female mice were mixed in IVC cages and given 3%
DSS (reagent-grade DSS salt, molecular mass: 36–50 kD, MP Biomedicals, Illkirch-Graffenstaden, FR)
in normal drinking water for 5 days. At Day 5, DSS-containing water was replaced by normal water.
Animals were sacrificed after 5 or 8 days, respectively. Loss of body weight was monitored daily
during the entire course of the experiment. After sacrificing the mice, colon lengths were measured.
Colons were snap frozen or fixed in 4% paraformaldehyde for further analysis.
4.9. Histology Scoring
Fixed tissues were embedded in paraffin, cut and stained with hematoxylin and eosin.
Histopathological alterations were scored by a pathologist using a scoring system with the following
parameters: cellular infiltration in the lamina propria of the large bowel (score from 0 to 3), crypt abscesses
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(score from 0 to 3), loss of goblet cells (score 0 to 3), epithelial erosion (score 0 to 1), hyperemia (score from
0 to 2), and thickness of mucosa (score from 0 to 3). The range of scores was from 0 (not affected) to 15
(most severe).
4.10. qPCR Analysis
Total RNA was isolated from 5 × 106 neutrophils using the SV total RNA isolation system
(Promega, Wallisellen, Switzerland) and subsequently reverse-transcribed using oligo d(T) primers and
M-MLV reverse transcriptase (Promega) according to the manufacturer’s instructions. Quantitative
RT-PCR (qPCR) analysis was performed using HOT FIREPol® EvaGreen® qPCR Mix Plus from
Solis Biodyne (Tartu, Estonia) on a Real-Time PCR machine (iQ5, Bio-Rad Laboratories AG,
Cressier, Switzerland). Primer sequences were the following: mTnfα (TNFα, amplicon 128 bp) Fw
5′-ATGAGAAGTTCCCAAATGGC, Rev 5′-CACTTGGTGGTTTGCTACGAC; mIl-6 (IL-6, amplicon
73 bp) Fw 5′-ACAAGTCGGAGGCTTAATTACACAT, Rev 5′-TTGCCATTGCACAACTCTTTT; mMmp9
(MMP9, amplicon 62 bp) Fw 5′-GCAGAGGCATACTTGTACCG, Rev 5′-TGCTTCTCTCCCATCATCTG;
reference gene mGapdh (GAPDH, amplicon 124 bp) Fw 5′-CCTCGTCCCGTAGACAAAATG, Rev
5′-TGAAGGGGTCGTTGATGGC.
4.11. Statistical Analysis
Data were analyzed using the student’s t-test. All values represent means ± SEM. p < 0.05 (*),
p < 0.01 (**), p < 0.005 (***) and p < 0.001 (****) were considered as statistically significant. Statistical
analysis was performed using GraphPad Prism 6 software (La Jolla, CA, US).
Supplementary Materials: Supplementary Materials can be found at www.mdpi.com/xxx/s1.
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Abbreviations
BID BH3-Interacting Domain Death Agonist
DSS Dextran Sulfate Sodium
GM-CSF Granulocyte-Macrophage colony-Stimulating Factor
IBD Inflammatory Bowel Disease
IL-6 Interleukin-6
LPS Lipopolysaccharide
Q-VD-OPh Quinoline-Val-Asp-Difluorophenoxymethylketone
TNFα Tumor Necrosis Factor Alpha
WT Wild-type
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